US EditionFDA Panel on the Use of Antidepressants During Pregnancy Is Alarming Experts
UNITED STATES, JUL 23 – FDA expert panel debated potential fetal risks and maternal benefits of SSRIs in pregnancy amid conflicting views and noted that 6% of pregnant women use these antidepressants, studies show.
- A 10-member expert panel assembled by the Food and Drug Administration on Monday morning reviewed SSRIs during pregnancy, including fluoxetine , sertraline , and citalopram .
- Amid pressure from the Make America Healthy Again movement, the FDA prompted the panel, with Robert F. Kennedy Jr. leading the scrutiny of SSRI safety during pregnancy.
- Nine of the panel’s 10 members, mostly researchers and clinicians, questioned SSRI safety, while Dr. Kay Roussos-Ross, a maternal mood disorder specialist, argued SSRIs are safe for most pregnant patients.
- Amid the panel’s findings, experts warned, with `I’m surprised and disappointed by the amount of misinformation that was presented`, said Dr. Katie Unverferth, warning the panel could hinder women's access to needed care.
- Looking ahead, the FDA’s efforts, according to FDA spokesperson, suggest stronger warnings and regulatory reforms may follow, supported by emerging evidence.
31 Articles
31 Articles
Kennedy’s mental health drug skepticism lands at FDA panel
WASHINGTON — The Food and Drug Administration, making good on a Trump administration promise to examine usage of antidepressants, on Monday convened a panel largely of antidepressant skeptics to discuss the health impacts of taking such medicine while pregnant, though…
The Sun (Lowell)
FDA panel on the use of antidepressants during pregnancy is alarming experts
By Corinne Purtill, Los Angeles Times LOS ANGELES — The U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a class of antidepressant drugs long criticized by Health and Human Services Secretary Robert F. Kennedy Jr. On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications like fluoxetine (Prozac), sertraline (Zoloft) and citalopr…
Kennedy's mental health drug skepticism lands at FDA panel
The Food and Drug Administration, making good on a Trump administration promise to examine usage of antidepressants, on Monday convened a panel largely of antidepressant skeptics to discuss the health impacts of taking such medicine while pregnant, though several panelists have no particular expertise on pregnancy research. The panelists during the two-hour event essentially echoed the statements of Health and Human Services Secretary Robert F. …
FDA Expert Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy
An FDA expert roundtable on Selective Serotonin Reuptake Inhibitors (SSRIs) and pregnancy to facilitate discussions on the safety of the developing child. Held on July 21, 2025 and featuring, amongst others, David Healy, Adam Urato, Joanna Moncrieff, Josef Witt-Doerring and Roger McFillin. The post FDA Expert Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy appeared first on Mad In America.
Australian National Review - Antidepressants During Pregnancy Raise Risk of Birth Defects, Doctors Tell FDA
Antidepressants During Pregnancy Raise Risk of Birth Defects, Doctors Tell FDA By Suzanne Burdick, Ph.D. The FDA needs to do a better job of warning pregnant women that taking SSRIs, a class of antidepressants, may harm them and their developing baby, doctors told the agency on Monday. The U.S. Food and Drug Administration (FDA) needs to do a better job of warning pregnant women that taking SSRIs, a type of antidepressant, may harm them and thei…
Coverage Details
Bias Distribution
- 74% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
